Amneal Pharmaceuticals, Inc.
A maker of generic and specialty medicines, Amneal Pharmaceuticals develops, manufactures and distributes hundreds of medications—from pills and injections to eye drops, creams and transdermal patches—that patients and pharmacies use every day. Founded in 2002 by brothers Chirag and Chintu Patel, the company grew from a bootstrapped family venture in New Jersey into one of the largest generic drugmakers in the United States. Fun fact: the name "Amneal" blends the founders' names, Amar and Neal.
Sold 5.00M
Granted 1.57M · Bought 500.0K
Granted 1.57M · Bought 500.0K
Bought 1.97M
Sold 3.88M
Granted 325.8K · Bought 200.0K · Sold 480.0K
Granted 507.1K · Bought 353.6K
Granted 1.61M · Sold 599.7K
Granted 1.38M · Sold 611.9K
Granted 320.8K · Bought 23.8K
Granted 337.1K
Granted 173.3K · Bought 55.0K · Sold 37.8K
Granted 325.8K · Bought 50.0K · Sold 50.0K
Granted 320.8K
Granted 1.58M · Bought 85.7K · Sold 529.7K
Granted 697.7K · Sold 169.3K
Granted 349.3K · Bought 10.0K · Sold 99.1K
Granted 291.0K · Sold 80.0K
Granted 102.6K
Granted 206.5K · Sold 112.8K
Granted 94.7K · Sold 11.7K
Granted 106.1K · Sold 23.3K
Granted 83.3K · Bought 17.0K
Bought 37.0K
Granted 25.0K · Bought 17.0K
Granted 27.6K
Granted 18.3K
Granted 20.1K
Granted 16.5K
Granted 6.1K
Granted 6.1K
Sold 46.85M
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Patel Tushar Bhikhubhai10% owner · 2 transactions | — | 48.58Mas of Mar 2025 | — | — | 5.00M |
| Patel DipanMember of 13D Group · 1 transaction | — | 26.91Mas of Nov 2023 | — | — | — |
| Patel ChintuCo-CEO, Director · 20 transactions | — | 26.17M | 1.57M | 500.0K | — |
| Patel Chirag K.President & Co-CEO, Director · 20 transactions | — | 22.66M | 1.57M | 500.0K | — |
| Fosun International Ltd10% owner · 2 transactions | — | 18.41Mas of Aug 2019 | — | 1.97M | — |
| Bonderman David +3 co-filersFormer 10% Owner · 1 transaction | — | 12.33Mas of Dec 2022 | — | — | 3.88M |
| Patel GautamDirector · 27 transactions | — | 1.64M | 325.8K | 200.0K | 480.0K |
| Meister Paul MDirector · 10 transactions | — | 832.8K | 507.1K | 353.6K | — |
| Konidaris TasosExecutive Vice President & CFO · 38 transactions | — | 449.4K | 1.61M | — | 599.7K |
| Shah NikitaExecutive Vice President · 70 transactions | — | 399.8K | 1.38M | — | 611.9K |
| George Jeffrey P.Director · 8 transactions | — | 344.6K | 320.8K | 23.8K | — |
| Buchi J KevinDirector · 10 transactions | — | 337.1K | 337.1K | — | — |
| Todisco JosephExecutive Vice President · 25 transactions | — | 327.2Kas of May 2022 | 173.3K | 55.0K | 37.8K |
| Nark Ted CDirector · 10 transactions | — | 325.8K | 325.8K | 50.0K | 50.0K |
| Yanai ShlomoDirector · 7 transactions | — | 320.8K | 320.8K | — | — |
| Boyer Andrew SExecutive Vice President · 73 transactions | — | 273.6K | 1.58M | 85.7K | 529.7K |
| Daly Jason B.EVP, Chief Legal Officer · 29 transactions | — | 267.4K | 697.7K | — | 169.3K |
| Kiely JohnDirector · 12 transactions | — | 260.3K | 349.3K | 10.0K | 99.1K |
| Alva Emily PetersonDirector · 8 transactions | — | 211.0Kas of May 2025 | 291.0K | — | 80.0K |
| Burr Robert LDirector · 4 transactions | — | 102.6Kas of May 2019 | 102.6K | — | — |
| Autor Deborah M.Director · 9 transactions | — | 93.7K | 206.5K | — | 112.8K |
| Reasons Bryan M.CFO · 2 transactions | — | 83.0Kas of Aug 2018 | 94.7K | — | 11.7K |
| Terreri Peter RDirector · 5 transactions | — | 82.8Kas of May 2020 | 106.1K | — | 23.3K |
| Stewart Robert APresident and CEO, Director · 3 transactions | — | 78.7Kas of May 2019 | 83.3K | 17.0K | — |
| Bhadauria PradeepSVP, Chief Scientific Officer · 2 transactions | — | 37.5Kas of Aug 2019 | — | 37.0K | — |
| Hirt SheldonSVP, GC & Corp. Sec. · 1 transaction | — | 35.0Kas of Jul 2018 | — | — | — |
| Bisaro PaulExecutive Chairman, Director · 3 transactions | — | 29.5Kas of May 2019 | 25.0K | 17.0K | — |
| Buchen David ASVP, Chief Legal Officer · 2 transactions | — | 20.4Kas of Jan 2020 | 27.6K | — | — |
| Vergis Janet S.Director · 2 transactions | — | 18.3Kas of May 2019 | 18.3K | — | — |
| Branning Todd P.SVP and CFO · 2 transactions | — | 12.8Kas of Jan 2020 | 20.1K | — | — |
| Manzano StephenSVP, General Counsel · 2 transactions | — | 10.7Kas of Feb 2021 | 16.5K | — | — |
| Greene Jean SeldenDirector · 1 transaction | — | 6.1Kas of May 2019 | 6.1K | — | — |
| Rama DharmendraDirector · 1 transaction | — | 6.1Kas of May 2019 | 6.1K | — | — |
| APHC Holdings, LLC10% owner · 7 transactions | — | 0as of Jul 2018 | — | — | 46.85M |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -54.72M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.